Related Experiment Video
Updated: Feb 13, 2026
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
Published on: August 29, 2016
Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models
Yan Ting Shue1,2, Jing Shan Lim1,2, Julien Sage1,2
1Department of Pediatrics, Stanford University, Stanford, CA, USA.
Abstract:
Small cell lung carcinoma (SCLC) is a fast-growing, highly metastatic form of lung cancer. A major difference between SCLC and other forms of lung cancer is that SCLC tumors often respond well to chemotherapy initially; unfortunately, resistant tumors rapidly recur. In addition, despite a large number of clinical trials with a variety of therapeutic agents, little progress has been achieved in the past three decades in improving the survival of SCLC patients. These clinical observations indicate that SCLC tumors have a high degree of plasticity and rapid adaptability to changes in growth conditions. Here we consider recent evidence pointing to several levels of heterogeneity in SCLC that may explain the ability of these tumors to adjust to different microenvironment and therapeutics. In particular, we review new data pointing to the existence of several subpopulations of tumor cells that interact with each other to promote tumor growth. We also discuss how SCLC tumors that look similar at the histopathological level may actually represent distinct subtypes of tumors and how these differences impact the response to specific therapeutic agents. A better understanding of genetic and cellular heterogeneity will guide the development of personalized approaches to help SCLC patients.
Insights
Small cell lung carcinoma (SCLC) exhibits rapid growth and metastasis. Understanding SCLC heterogeneity is key to overcoming treatment resistance and improving patient survival.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Small cell lung carcinoma (SCLC) is an aggressive cancer characterized by initial chemosensitivity followed by rapid, resistant recurrence.
- Despite extensive research and clinical trials, therapeutic advancements for SCLC have been limited over the last 30 years.
- SCLC's clinical behavior suggests significant tumor plasticity and adaptability to therapeutic pressures and microenvironmental changes.
Purpose of the Study:
- To review current evidence on the heterogeneity of SCLC at genetic and cellular levels.
- To explore how this heterogeneity contributes to SCLC's adaptability, therapeutic resistance, and clinical outcomes.
- To highlight the potential of understanding heterogeneity for developing personalized SCLC treatments.
Main Methods:
- Review of recent scientific literature and clinical trial data concerning SCLC.
- Analysis of studies investigating cellular subpopulations and their interactions within SCLC tumors.
- Examination of histopathological and molecular data to identify distinct SCLC subtypes.
Main Results:
- SCLC tumors display significant heterogeneity, including distinct cell subpopulations that collaborate for tumor progression.
- Histopathologically similar SCLC tumors can represent diverse subtypes with varying responses to treatments.
- Tumor plasticity and adaptability are linked to underlying genetic and cellular heterogeneity.
Conclusions:
- Understanding the multifaceted heterogeneity of SCLC is crucial for improving treatment strategies.
- Identifying distinct SCLC subtypes can inform the development of more effective, personalized therapeutic approaches.
- Targeting SCLC heterogeneity offers a promising avenue for enhancing patient survival and outcomes.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:01pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
01:47Lung Capacity
01:24Defining Psychology
02:41Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...